---
title: "Balchem Corporation (BCPC.US) — Company Overview"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/BCPC.US/overview.md"
symbol: "BCPC.US"
name: "Balchem Corporation"
parent: "https://longbridge.com/en/quote/BCPC.US.md"
datetime: "2026-04-05T12:18:19.908Z"
locales:
  - [en](https://longbridge.com/en/quote/BCPC.US/overview.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BCPC.US/overview.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BCPC.US/overview.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/BCPC.US/overview.md) | [繁體中文](https://longbridge.com/zh-HK/quote/BCPC.US/overview.md)


# Balchem Corporation (BCPC.US) — Company Overview

## Basic Information

| Item | Detail |
|------|--------|
| Industry | Specialty Chemicals |
| Exchange | US Market |
| Address | 5 Paragon Drive, Montvale, New Jersey, United States |
| Website | [www.balchem.com](https://www.balchem.com) |

## Company Profile

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates.

## Key Executives

| Name | Title |
|------|-------|
| Theodore Lee Harris | CEO, President & Chairman |
| Carl Martin Bengtsson | Executive VP, CFO, Treasurer and GM of Animal Nutrition & Health |
| Hatsuki Miyata | Executive VP, Chief Legal Officer & Secretary |
| Martin Luther Reid | Senior VP & Chief Supply Chain Officer |
| Frederic Boned | Senior VP, Head of Digital Transformation & AI and GM of Human Nutrition & Health |
| Matthew D. Wineinger | Lead Independent Director |
| Daniel E. Knutson | Independent Director |
| Kathleen B. Fish | Independent Director |
| David B. Fischer | Independent Director |

## Major Shareholders

| Name | Ratio | Report Date |
|------|-------|-------------|
| BlackRock, Inc. | 15.33% | 2025-12-31 |
| The Vanguard Group, Inc. | 12.10% | 2025-12-31 |
| State Street Global Advisors, Inc. | 3.78% | 2025-12-31 |
| Conestoga Capital Advisors, LLC | 3.76% | 2025-12-31 |
| Wasatch Advisors LP | 3.69% | 2025-12-31 |
| Geode Capital Management, LLC | 3.14% | 2025-12-31 |
| Nationwide Fund Advisors | 2.76% | 2025-12-31 |
| Eaton Vance Management | 2.17% | 2025-12-31 |
| Dimensional Fund Advisors LP | 1.87% | 2025-12-31 |
| FMR LLC | 1.66% | 2025-12-31 |

## Business Breakdown

| Segment | Revenue | Ratio |
|---------|---------|-------|
| Human Nutrition & Health | 659387000 | 63.58% |
| Animal Nutrition & Health (Excl Industrial Products) | 230852000 | 22.26% |
| Specialty Products | 140976000 | 13.59% |
| Other and Unallocated | 5946000 | 0.57% |

```vega-lite
{
  "$schema": "https://vega.github.io/schema/vega-lite/v5.json",
  "title": "Balchem Corporation Business Breakdown",
  "data": {
    "values": [
      {
        "segment": "Human Nutrition & Health",
        "ratio": 63.58
      },
      {
        "segment": "Animal Nutrition & Health (Excl Industrial Products)",
        "ratio": 22.26
      },
      {
        "segment": "Specialty Products",
        "ratio": 13.59
      },
      {
        "segment": "Other and Unallocated",
        "ratio": 0.57
      }
    ]
  },
  "mark": "arc",
  "encoding": {
    "theta": {
      "field": "ratio",
      "type": "quantitative"
    },
    "color": {
      "field": "segment",
      "type": "nominal"
    }
  }
}
```

## Geographic Segments

| Region | Revenue | Ratio |
|--------|---------|-------|
| United States | 759448000 | 73.22% |
| Foreign Countries | 277713000 | 26.78% |


---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**